Publication | Open Access

Cytochrome b5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy

Pharmacological EfficacyBiochemistryMedicineLipid PeroxidationMechanism Of ActionAnti-cancer AgentCytochromes P450 1A1PharmacologyAnticancer Drug EllipticineRedox BiologyDrug DiscoveryOxidative Stress